Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-08-11

Clinical Trial Update: Pharmacokinetics Study of VALTOCO® in Pediatric Subjects With Epilepsy [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on the pharmacokinetics of VALTOCO (diazepam nasal spray) in pediatric subjects with epilepsy, covering Phase 1 and Phase 2; the study sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VALTOCO (diazepam nasal spray)

Snippet

Sponsor: Neurelis, Inc. | Conditions: Epilepsy | Phase 1, Phase 2 | Status: COMPLETED